UNIGE document Scientific Article - Review
previous document  unige:21441  next document
add to browser collection

BARD1, a possible biomarker for breast and ovarian cancer

Published in Gynecologic oncology. 2010, vol. 117, no. 2, p. 211-5
Abstract Breast cancer is the leading cause of cancer death in women. Ovarian cancer, although less frequent, is detected very late, and survival is correlated to early detection. Therefore, better methods for early detection would help to increase the number of survivors. The incidence of young women diagnosed with breast cancer is increasing. These women and women who are at risk because of a family history of breast cancer would benefit from more accurate and less invasive screening methods than those in place today. A blood test based on BARD1, a protein that interacts with the breast cancer gene product BRCA1, is a promising candidate for fulfilling these conditions. The science behind BARD1 and its role in breast and ovarian cancer is explained in this article.
Keywords Breast Neoplasms/blood/geneticsFemaleGenetic Predisposition to DiseaseHumansOvarian Neoplasms/blood/geneticsTumor Markers, Biological/blood/geneticsTumor Suppressor Proteins/blood/geneticsUbiquitin-Protein Ligases/blood/genetics
PMID: 19959210
Full text
Article (Published version) (497 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
IRMINGER, Irmgard. BARD1, a possible biomarker for breast and ovarian cancer. In: Gynecologic oncology, 2010, vol. 117, n° 2, p. 211-5. doi: 10.1016/j.ygyno.2009.10.079 https://archive-ouverte.unige.ch/unige:21441

496 hits

0 download


Deposited on : 2012-05-25

Export document
Format :
Citation style :